Lineage-specific transcriptomic signatures and therapeutic target discovery in myeloid and lymphoid leukemias
This integrative approach links transcriptomics with drug discovery and preclinical validation. Lineage-specific vulnerabilities were uncovered, providing a framework for precision therapy and rational drug repurposing in leukemia.
Authors
- Başak Özay (ORCID: https://orcid.org/0000-0003-0712-8712)
- Yağmur Kiraz (ORCID: https://orcid.org/0000-0003-3508-5617)
- Onur Ateş
Institutions
- İzmir University of Economics (TR)
Publication Details
- Journal
- Personalized Medicine
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/17410541.2025.2600908
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00